| This week's sponsor is Premier Research. | |  | Overcoming Risk in Oncology Drug Development
Oncology drug development is fraught with obstacles and risks, and you must carefully plan each step. Click here for tips on finding the fast track. Premier Research. It's what we do. Best. |
Today's Rundown Featured Story | | | Thursday, May 9, 2019 Bicycle Therapeutics has hired clinical and program management leaders to support development of its anticancer candidates. The hires provide Bicycle with clinical trial expertise at a time when it is contending with the resignation of its chief medical officer. |
|
|
Top Stories Thursday, May 9, 2019 Spectrum Pharmaceuticals has acquired an early-phase anti-CD20 cancer asset from ImmunGene as part of a broader deal. The agreement gives Spectrum an antibody-interferon fusion technology drug delivery platform designed to generate oncology candidates. Thursday, May 9, 2019 Blaze Bioscience, a company working on a fluorescent molecule to help surgeons better remove tumors, reported data from a phase 1 trial testing its “tumor paint” in adults with gliomas, a type of brain cancer. Thursday, May 9, 2019 Artificial intelligence in clinical trials is all the rage, and Janssen has become the latest Big Pharma to delve deeper into its potential to boost the number of successful drugs coming through the pipeline. Thursday, May 9, 2019 Cancer immunotherapies can effectively tackle many tumor types. But for notoriously hard-to-treat brain cancer—and after a couple of failed trials—hope seems less realistic, at least for Bristol-Myers Squibb’s Opdivo. Resources Sponsored by: Catalent Download the executive summary to learn key considerations for a successful technology transfer for manufacturing drug products, including a case study on overcoming challenges in a process transfer for a sterile diluent. Sponsored by: Patheon, part of Thermo Fisher Scientific Choosing the Best Sterile Dosage Form for Your Phase I Clinical Supply Needs. Sponsored by: Patheon, part of Thermo Fisher Scientific Designed with speed & flexibility,Quick to Clinic™ for Oral Solid Dose helps deliver products to Phase I Clinic in as little as 14 weeks. Sponsored by: AlphaSense What is agile competitive intelligence, and how can help healthcare researchers stay ahead of the curve? Sponsored by: JPEO-CBRND – Medical Countermeasure Systems MCS is currently seeking broad-based industry/academia collaboration on research and prototype work in technical areas related to developing medical countermeasures for the Joint Warfighter. Sponsored by: Outer Edge Technology Learn how the cloud can support the performance and security requirements for validated, mission-critical applications historically designed and implemented exclusively via on-premises deployment. Sponsored by: Elemental Machines Learn how cloud-connected IoT sensors are transforming operations in leading life science labs. Read our white paper “The Smart Lab”. Presented by: Total Brain Total Brain Announces Personalized Test for Treatment Prediction in Depression with 80% Accuracy. Sponsored by: Veradigm Prescription price transparency technology is here – but is it making a difference? Find out HERE. Sponsored by: Strativity Every life sciences firm talks about patient-centricity, but are you doing what it takes to deliver? Sponsored by: Biotech Primer The Biopharma industry is moving at lightning speed and it can be a challenge to keep pace. Here at Biotech Primer we spend hours each week researching, writing, and editing original content for the Biotech Primer WEEKLY with one goal in mind: to help everyone better understand the latest science and technology driving today’s healthcare industry. | 
